"CD5 Antigens" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Glycoproteins expressed on all mature T-cells, thymocytes, and a subset of mature B-cells. Antibodies specific for CD5 can enhance T-cell receptor-mediated T-cell activation. The B-cell-specific molecule CD72 is a natural ligand for CD5. (From Abbas et al., Cellular and Molecular Immunology, 2d ed, p156)
| Descriptor ID |
D018956
|
| MeSH Number(s) |
D23.050.301.264.051.101 D23.050.301.264.894.101 D23.101.100.150.101 D23.101.100.894.101
|
| Concept/Terms |
CD5 Antigens- CD5 Antigens
- T1 Antigen
- Leu-1 Antigen
- Leu 1 Antigen
- CD5 Antigen
- Antigen, CD5
- Antigens, CD5
|
Below are MeSH descriptors whose meaning is more general than "CD5 Antigens".
- Chemicals and Drugs [D]
- Biological Factors [D23]
- Antigens [D23.050]
- Antigens, Surface [D23.050.301]
- Antigens, Differentiation [D23.050.301.264]
- Antigens, Differentiation, B-Lymphocyte [D23.050.301.264.051]
- CD5 Antigens [D23.050.301.264.051.101]
- Antigens, Differentiation, T-Lymphocyte [D23.050.301.264.894]
- CD5 Antigens [D23.050.301.264.894.101]
- Biomarkers [D23.101]
- Antigens, Differentiation [D23.101.100]
- Antigens, Differentiation, B-Lymphocyte [D23.101.100.150]
- CD5 Antigens [D23.101.100.150.101]
- Antigens, Differentiation, T-Lymphocyte [D23.101.100.894]
- CD5 Antigens [D23.101.100.894.101]
Below are MeSH descriptors whose meaning is more specific than "CD5 Antigens".
This graph shows the total number of publications written about "CD5 Antigens" by people in this website by year, and whether "CD5 Antigens" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1998 | 0 | 1 | 1 |
| 2006 | 1 | 0 | 1 |
| 2007 | 0 | 1 | 1 |
| 2009 | 1 | 2 | 3 |
| 2010 | 0 | 1 | 1 |
| 2014 | 1 | 0 | 1 |
| 2015 | 1 | 0 | 1 |
| 2016 | 0 | 1 | 1 |
| 2017 | 1 | 1 | 2 |
| 2024 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "CD5 Antigens" by people in Profiles.
-
Chimeric antigen receptor-induced antigen loss protects CD5.CART cells from fratricide without compromising on-target cytotoxicity. Cell Rep Med. 2024 Jul 16; 5(7):101628.
-
Reversible Transgene Expression Reduces Fratricide and Permits 4-1BB Costimulation of CAR T Cells Directed to T-cell Malignancies. Cancer Immunol Res. 2018 01; 6(1):47-58.
-
Primary adrenal diffuse large B-cell lymphoma positive for CD5 and CD10. Rinsho Ketsueki. 2017; 58(2):161-164.
-
CD123 Immunohistochemical Expression Is a Specific But Insensitive Marker of Early T-precursor Leukemia. Appl Immunohistochem Mol Morphol. 2016 Jan; 24(1):e4-5.
-
A T-cell-directed chimeric antigen receptor for the selective treatment of T-cell malignancies. Blood. 2015 Aug 20; 126(8):983-92.
-
CD5-positive follicular lymphoma: clinicopathologic correlations and outcome in 88 cases. Mod Pathol. 2015 Jun; 28(6):787-98.
-
Utility of quantitative flow cytometry immunophenotypic analysis of CD5 expression in small B-cell neoplasms. Arch Pathol Lab Med. 2014 Jul; 138(7):903-9.
-
Role of PAX-8, CD5, and CD117 in distinguishing thymic carcinoma from poorly differentiated lung carcinoma. Appl Immunohistochem Mol Morphol. 2014 May-Jun; 22(5):372-6.
-
Clinicopathologic features of CD5-positive nodal marginal zone lymphoma. Am J Clin Pathol. 2013 Nov; 140(5):693-700.
-
CD5-positive mucosa-associated lymphoid tissue (MALT) lymphoma: a clinicopathologic study of 14 cases. Hum Pathol. 2012 Sep; 43(9):1436-43.